BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
DNA fingerprint
,
Bleomycin
,
rs4950928
,
TGFB1
,
Angiogenesis
,
Leukemia
,
Leukocyte
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
5 n- ethylcarboxamidoadenosine
Summary
General Info
Curated Studies
Most Correlated Studies
Multiple myeloma cells treated with A2A and Beta-2 Adrenergic Receptor agonists with dexamethasone
Murine pituitary folliculostellate TtT/GF cells treated with 5'-N-ethylcarboxamidoadenosine
Explore Curated Studies Results
Literature
Most Relevant Literature
Reno-protective effect of NECA in diabetic nephropathy: implication of IL-18 and ICAM-1.
Effect of fluoxetine and adenosine receptor NECA agonist on G alpha q/11 protein of C6 glioma cells.
Finding NECA: zebrafish screen identifies key signalling pathway in β-cell regeneration.
Effect of fluoxetine or adenosine receptor NECA agonist on G-proteins of C6 glioma cells or NK immun…
Adenosine receptor agonist NECA increases cerebral extravasation of fluorescein and low molecular we…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for 5 n- ethylcarboxamidoadenosine
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ